Share
Pharmaceutical Intermediates Market: By Product (Chemical Intermediates, Bulk Drug Intermediates, Custom Intermediates), By Application (Analgesics, Anti-Inflammatory Drug, Cardiovascular Drugs, Anti-Diabetic Drugs, Antimicrobial Drugs, Anti-Cancer Drugs), By End User (Biotech and Pharma Companies, Research Laboratory, CMOs/CROs), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
Pharmaceutical intermediates are the chemical compounds that are broadly used for the production of different kinds of drugs in large quantities. They are also required for research and development by pharmaceutical and biotechnology firms. Active pharmaceutical compounds are produced from pharmaceutical intermediates (APIs). When APIs are made, pharmaceutical intermediates are created as a by-product. Each reaction in the manufacturing of API results in the development of various pharmaceutical intermediates. It can only be converted into API with additional molecular alterations or improvements. Intermediates may or may not be separated. In addition to being employed by numerous pharmaceutical and biopharmaceutical businesses for R&D, pharmaceutical intermediates are also used in the manufacturing of bulk medications.
Pharmaceutical Intermediates to surpass USD 48.5 billion by 2032 from USD 29.06 billion in 2021 at a CAGR of 4.8% in the coming years, i.e., 2022-32. The global Pharmaceutical Intermediates Market is growing as a result of the rising demand for pharmaceutical intermediates in the pharmaceutical and cosmetic sectors. In the pharmaceutical sector, research and development frequently use pharmaceutical intermediates. Over the forecast period, these factors are anticipated to drive the market.
Pharmaceutical Intermediates Market is categorized on the basis of Product into Chemical Intermediates, Bulk Drug Intermediates, and Custom Intermediates. The bulk drug intermediates are anticipated to hold a larger global share throughout the projected period since they are used to create active pharmaceutical ingredients (API). The main component of medications that produces the intended therapeutic effect is called API. Moreover, it is predicted that government programs to support and build bulk drug parks would fuel the growth of this market.
Pharmaceutical Intermediates Market is categorized on the basis of application into Analgesics, Anti-Inflammatory Drug, Cardiovascular Drugs, Anti-Diabetic Drugs, Antimicrobial Drugs, Anti-Cancer Drugs, and Others. The pharmaceutical intermediates market had a significant contribution from the analgesics segment. The segment is predicted to continue dominance in the near future as well since analgesics are often used to treat pain. This market is expanding as chronic conditions like arthritis, cancer, and cardiovascular disorders are becoming more common worldwide.
The surge in demand for necessary medications to treat chronic diseases has a significant impact on the demand for pharmaceutical intermediates. The demand for pharmaceutical intermediates for research purposes is also rising as a result of developments in technologies, such as high throughput, bioinformatics, and combinatorial chemistry for better drug candidate discovery. Therefore, it is anticipated that the use of pharmaceutical intermediates would continue to increase over the projected period due to increased production and research efforts in the pharmaceutical sector.
A number of small and medium-sized businesses are concentrating on increasing their production capacity, which is another driver anticipated to boost demand for pharmaceutical intermediates and subsequently drive the market. As a result, there is a growing need for pharmaceutical intermediate, and sales are expected to increase significantly through 2030. Major pharmaceutical firms are also increasingly using contract manufacturing firms to produce pharmaceutical intermediates and finished products.
In the upcoming years, the growth of the Pharmaceutical Intermediate Market is anticipated to be slowed down by strict regulatory policies. Another important aspect that could adversely affect the market growth indirectly is the high cost of purchasing biopharmaceutical medications. Another aspect limiting the market growth is the high capital expenditures required to produce APIs.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Pharmaceutical Intermediates Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In terms of revenue, North America dominated the market for pharmaceutical intermediates globally in 2020, and it is anticipated that it will continue to do so during the projected period. Due to the large number of pharmaceutical companies, research facilities, and laboratories as well as the quickly expanding CMOs & CROs in the US and Canada, North America dominates the market. Also, increasing public and private sector investments in the biopharmaceutical sector are anticipated to keep North America in the lead during the projected period.
The Asia Pacific market is anticipated to grow at a remarkable CAGR. The region's market is expected to grow due to the increasing geriatric population.
Get More Information - Download Free Sample
The growth of COVID-19 virus has increased the number of COVID-19 patients being admitted to hospitals, which has caused a scarcity of drug storage. Globally, a number of government agencies issued scarcity alerts for a number of medications, including possible COVID-19 therapies. The pandemic can have a variety of short- and long-term effects on the market for pharmaceutical intermediates, mostly due to constraints in the global supply chain that lead to a shortage of raw materials.
REPORT ATTRIBUTE |
DETAILS |
|
Market Size Value in 2021 |
USD 29.06 billion |
|
Revenue Forecast in 2032 |
USD 48.5 billion |
|
Growth Rate |
CAGR of 4.8% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Quantitative Units |
Revenue in USD billion and CAGR from 2022 to 2032 |
|
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments Covered |
Product, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key Companies Profiled |
BASF SE, Sanofi, Pfizer, Evonik Industries AG, Arkema Inc, Vertellus Holdings LLC, Dishman Group, Aceto Corporation, Codexis Inc., Midas Pharma GmbH, Interchem, Lonza Group, Chemcon Specialty Chemical Pvt. Ltd, Dextra Laboratories Limited, Chiracon GmbH, and Other Prominent Players. |
The Pharmaceutical Intermediates Market size was estimated at USD 29.06 billion in 2021 and is expected to reach USD 48.5 billion in 2032.
Pharmaceutical intermediates are the chemical compounds that are broadly used for the production of different kinds of drugs in large quantities.
The Bulk Drug Intermediates and Analgesics segments accounted for the larger share of the Pharmaceutical Intermediates Market.
Key players in the Pharmaceutical Intermediates Market are BASF SE, Sanofi, Pfizer, Evonik Industries AG, Arkema Inc, Vertellus Holdings LLC, Dishman Group, Aceto Corporation, Codexis Inc., Midas Pharma GmbH, Interchem, Lonza Group, Chemcon Specialty Chemical Pvt. Ltd, Dextra Laboratories Limited, Chiracon GmbH, and Other Prominent Players.
The global Pharmaceutical Intermediates Market is growing as a result of the rising demand for pharmaceutical intermediates in the pharmaceutical and cosmetic sectors.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
